Drug intelligence / Profile preview

Bacitraycin Plus

Development stage
Unknown
Lead developer
First Aid Research Corp.
Modality
Peptides, Small Molecules
Administration
Topical
01

Overview

Bacitraycin Plus (bacitracin + pain relief ointment) is an over-the-counter (OTC) topical first-aid ointment developed by First Aid Research. It is formulated to prevent infection and relieve pain in minor skin injuries, such as cuts, scrapes, and burns. The product combines bacitracin zinc, a polypeptide antibiotic that inhibits bacterial cell wall synthesis by binding to undecaprenyl pyrophosphate, with a local anesthetic—either pramoxine hydrochloride or lidocaine—which acts as a voltage-gated sodium channel blocker to alleviate pain and itching. It is applied topically to the affected area.

Brand names
Bacitraycin PlusBacitraycin Plus Max Pain Relief OintmentBacitraycin Plus Maximum StrengthFirst Aid Maximum Strength Bacitraycin PlusFirst Aid Research Bacitraycin Plus Maximum Vertical
Other names
bacitracin + lidocainebacitracin + pain relief ointmentbacitracin + pramoxinebacitracin zinc + lidocainebacitracin zinc + lidocaine hydrochloridebacitracin zinc + pramoxinebacitracin zinc + pramoxine hydrochloride
02

Targets

NaV (Voltage-gated sodium channels)C55-PP (Undecaprenyl pyrophosphate)

Beyond the preview

Go deeper on Bacitraycin Plus.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bacitraycin Plus.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call